Nepsis Inc. Acquires 5,021 Shares of The Cigna Group (NYSE:CI)

Nepsis Inc. grew its holdings in shares of The Cigna Group (NYSE:CI) by 10.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 54,456 shares of the health services provider’s stock after purchasing an additional 5,021 shares during the period. The Cigna Group comprises approximately 2.2% of Nepsis Inc.’s holdings, making the stock its 15th largest holding. Nepsis Inc.’s holdings in The Cigna Group were worth $15,037,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. ORG Wealth Partners LLC bought a new stake in The Cigna Group during the 4th quarter worth about $34,000. Ulland Investment Advisors LLC lifted its position in The Cigna Group by 2,500.0% during the 3rd quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after buying an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in The Cigna Group during the 3rd quarter worth about $37,000. Harbor Capital Advisors Inc. bought a new stake in The Cigna Group during the 3rd quarter worth about $45,000. Finally, Intact Investment Management Inc. bought a new stake in The Cigna Group during the 3rd quarter worth about $69,000. 86.99% of the stock is owned by institutional investors.

The Cigna Group Stock Performance

Shares of NYSE:CI opened at $294.18 on Friday. The company’s 50 day moving average price is $297.72 and its two-hundred day moving average price is $325.82. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83. The firm has a market cap of $81.82 billion, a PE ratio of 27.75, a PEG ratio of 0.78 and a beta of 0.54. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.22 by $0.29. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The firm had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. During the same quarter in the prior year, the business posted $6.77 EPS. The business’s revenue was up 29.8% compared to the same quarter last year. Equities research analysts predict that The Cigna Group will post 28.5 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Stephens reissued an “overweight” rating and set a $410.00 price target on shares of The Cigna Group in a research report on Friday, November 1st. Royal Bank of Canada lowered their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial lowered their price objective on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com lowered shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, Piper Sandler restated an “overweight” rating and set a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, The Cigna Group currently has a consensus rating of “Buy” and an average price target of $395.93.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.